Nelarabine Injection
Product Images NDC 71288-165

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nelarabine (NDC 71288-165). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Nel01 0000 01 V2)

Chemical structure of Nelarabine depicted in the image, showing its molecular arrangement with specific functional groups and stereochemistry.*

FDA Label Image

Principal Display Panel – Nelarabine Injection 50 mL Vial Label (Nel01 0000 02 V2)

Label for Nelarabine Injection 250 mg per 50 mL (5 mg per mL) single-dose vial by Meitheal Pharmaceuticals Inc. It is intended for intravenous infusion only, with instructions to discard unused portions. The label includes active ingredient content and storage directions.*

FDA Label Image

Principal Display Panel – Nelarabine Injection 50 mL Carton (Nel01 0000 03 V3)

Nelarabine Injection 250 mg per 50 mL (5 mg per mL) intravenous infusion in a carton for 6 single-dose vials. The label includes dosage form, strength, administration route, and storage instructions. Produced by Meitheal Pharmaceuticals Inc, the packaging features a blue and orange oval design with detailed product and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.